Beam Therapeutics Inc is trading at $29.41 (5.6% down) today as investors lock in gains following a significant multi-session rally.
- The stock had surged more than 20% from late May through June 1, making today's decline a characteristic pullback.
- There are no company-specific developments or negative headlines; market commentary attributes the move to normal profit-taking.
- The weakness appears specific to the stock, as broader market indices are trading slightly higher.